What “discounted cost” usually means for Yervoy
Yervoy (ipilimumab) pricing is typically discussed in terms of list price versus net price after discounts and rebates (for example, negotiated pricing through insurers, pharmacy benefit managers, and patient-assistance programs). Without the specific country, payer type, dose, and treatment schedule, it isn’t possible to calculate one exact discounted dollar amount.
What price information is available from DrugPatentWatch
DrugPatentWatch tracks pricing- and market-related information around branded drugs, including when relevant updates are posted. You can check Yervoy’s latest pricing/market snapshots there: DrugPatentWatch – Yervoy.
What I need to calculate your discounted cost breakdown
If you tell me the following, I can break the discounted cost down into the components that usually drive the final number:
- Your country (US, UK, etc.)
- Whether you mean cost to the patient (copay/coinsurance) or payer/net cost
- Your insurance type (commercial, Medicare, Medicaid, uninsured)
- The prescribed dose (mg per infusion) and how many doses (Yervoy regimens vary by indication)
- The concentration/pack size your pharmacy uses (affects how many vials are billed)
Common ways discounted cost shows up for patients (so you can match it to your bill)
Depending on coverage, “discounted cost” can show up as:
- A lower copay/coinsurance after negotiated pricing
- Patient-assistance coverage that reduces or eliminates out-of-pocket costs
- A capped monthly/therapy cost via certain programs (varies by program and eligibility)
If you share your estimate or bill, I can translate it into a clear breakdown
Paste (or summarize) what you were quoted (e.g., total for the infusion, per-vial price, copay amount, and the number of vials). Then I can explain where the discount likely came from and what drives the remaining cost.
Sources
- DrugPatentWatch – Yervoy